POZ Community Forums

Meds, Mind, Body & Benefits => Research News & Studies => Topic started by: Almost2late on September 23, 2020, 08:35:33 pm

Title: Studies say that Lamivudine may lower risk of Diabetes
Post by: Almost2late on September 23, 2020, 08:35:33 pm
Lamivudine, the drug in Triumeq, Dovato and Epzicom may be helping lower your chances of developing type 2 diabetes according to this article.
If true, this great for the aging HIV positive community, myself included.

Quote
"Researchers found that patients taking the drugs had a 33% lower risk of developing diabetes. The scientists say that the risk reduction makes sense based on how the drugs are known to work, and noted that one of the drugs, lamivudine, improved insulin sensitivity significantly in human cell samples and in a mouse model of diabetes"...

Read more..
https://medicalxpress.com/news/2020-09-hiv-drugs-diabetes.amp
Title: Re: Studies say that Lamivudine may lower risk of Diabetes
Post by: CircularNatural on November 01, 2021, 03:15:48 pm
Hey everyone!
I recently found this piece of news that found very interesting and worthy of taking into account, especially for PLWHIV that have metabolic syndrome and/or diabetes.

You can read about it here:

https://www.nature.com/articles/s41467-020-18528-z (https://www.nature.com/articles/s41467-020-18528-z)
https://newsroom.uvahealth.com/2020/09/23/hiv-drugs-could-prevent-diabetes-study-suggests/ (https://newsroom.uvahealth.com/2020/09/23/hiv-drugs-could-prevent-diabetes-study-suggests/)

Hope we learn more about this!

Take care all of you!
Title: Re: Studies say that Lamivudine may lower risk of Diabetes
Post by: Jim Allen on November 01, 2021, 03:28:46 pm
I merged the threads.

Jim.